COUNTRY Veterinary certificate to EU

I.1. Consignor

Name Address Postal code

I.2.

I.2.a. Local reference number:

I.3. Central Competent Authority

I.4. Local Competent Authority

I.5. Consignee Name Address Postal code

I.6.

I.7. Country of origin

ISO code

I.8. Region of origin

Code

I.9. Country of destination

ISO code

I.10. Region of destination

Code

I.11. Place of origin Embryo team

Name Approval number

Address Name Approval number

Address Name Approval number

Address

I.12. Place of destination Holding Embryo team Approved body

Name Approval number

Address Postal code

I.13.

I.14. Estimated date and time of arrival

I.15. Means of transport Aeroplane Ship Railway wagon

Road vehicle Other

Identification:

Documentary references:

I.16.

I.17.

I.18. Description of commodity

I.19. Commodity code (HS code)

I.20. Quantity

I.21.

I.22. Number of packages

I.23. Identification of container/Seal number

I.24.

I.25. Commodity certified for Artificial reproduction

I.26. For transit to third Country vis-à-vis EU

third country ISO code

I.27. For import or admission into EU

Definitive import

I.28. Identification of the animals/products Species (Scientific name) Identification mark Category Approval number of the team

Part I: Details of dispatched consignment

COUNTRY In vivo-derived bovine embryos

II. Health information

II.a. Certificate reference number

II.b. Local reference number

I, the undersigned, official veterinarian of the Government of , (insert name of exporting country)

certify that:

1.1. the embryo collection team identified above:

has been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC,

carried out the collection, processing, storing and transport of the embryos described above in accordance with Chapter II of Annex A to Directive 89/556/EEC,

subject to inspection by an official veterinarian at least twice a year;

1.2. the embryos to be exported were collected in the exporting country, which according to official findings:

1.2.1. was free from rinderpest during the 12 months immediately prior to their collection;

1.2.2.

1.2.2.1. either was free from foot-and-mouth disease during the 12 months immediately prior to their collection and did not carry out vaccination against foot-and-mouth disease during that period (1);

1.2.2.2. or was not free from foot-and-mouth disease during the 12 months immediately prior to their collection and/or carried out vaccination against foot-and-mouth disease during that period, and

the embryos were not subjected to penetration of the zona pellucida,

the embryos were stored under approved conditions for at least 30 days immediately after their collection, and

the donor females come from holdings on which no animal was vaccinated against foot-and-mouth disease during the 30 days prior to collection and no animal of a susceptible species showed clinical signs of foot-and-mouth disease during the 30 days prior to, and at least the 30 days after, the embryos were collected (1);

1.3.

1.3.1. within a 10 km radius of the premises on which the embryos to be exported were collected and processed, according to official findings there was no incidence of foot-and-mouth disease, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia in the 30 days immediately prior to their collection and, in the case of embryos certified under 1.2.2.2, in the 30 days after their collection as well;

1.3.2. from the time of collection until 30 days thereafter (or, in the case of fresh embryos, until the day of dispatch), the embryos to be exported were stored at all times on approved premises within a 10-km radius of which, according to official findings, there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever;

1.4. the donor females:

1.4.1. were located, during the 30 days immediately prior to collection of the embryos to be exported, on premises within a 10 km radius of which, according to official findings, there was no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia;

1.4.2. showed no clinical signs of disease on the day of collection:

1.4.3. spent the six months immediately prior to collection within the territory of the exporting country in no more than two herds:

which, according to official findings, were free from tuberculosis during that time,

which, according to official findings, were free from brucellosis during that time,

which were free from enzootic bovine leukosis or in which no animal showed clinical signs of enzootic bovine leukosis during the previous three years,

in which no bovine animal showed clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis during the previous 12 months;

Part II: Certification

1.5. the embryos to be exported provide the following additional guarantees (3):

1.5.1. either the embryos were collected in the exporting country, which according to official findings is free from Akabane disease (1),

1.5.2. or the embryos were collected in the exporting country, which according to official findings is not free from Akabane disease (1), and

the embryos were not subjected to penetration of the zona pellucida,

the embryos were stored under approved conditions for at least 30 days immediately after their collection, and

the donor females underwent a serum neutralisation test for Akabane disease, carried out on a blood sample taken not less than 21 days following their collection (1) and giving negative results;

1.6. the embryos to be exported were conceived by artificial insemination using semen coming from semen collection or storage centres approved for the collection, processing and/or storage of semen by the competent authority of a country listed in Annex I to Commission Decision 2004/639/EC (4) or by the competent authority of a Member State of the European Community.

Notes

(1) Delete as appropriate.

(2) (Box reference No I.28 in Part I):

Identification mark: corresponding to the identification on the straw of the donor cows and the date of collection.

Category: specify if (a) penetration or (b) non penetration of zona pellucida.

Approval number of the team: to be filled in if different from box No I.11.

(3) See remarks for exporting country concerned in Annex I to Decision 2006/168/EC.

(4) OJ L 292, 15.9.2004, p. 21.

(5) The signature and the stamp must be of a different colour from that of the printed form.

NB: This certificate must:

(a) be drawn up in at least one official language of the Member State of destination and of the Member State where the embryos will enter Community territory;

(b) be made out to a single consignee;

(c) accompany the embryos in the original.

Official veterinarian Name (in capital letters): Qualification and title

Date: Signature:

Stamp

COUNTRY Veterinary certificate to EU

I.1. Consignor

Name Address Postal code

I.2.

I.2.a. Local reference number:

I.3. Central Competent Authority

I.4. Local Competent Authority

I.5. Consignee Name Address Postal code

I.6.

I.7. Country of origin

ISO code

I.8. Region of origin

Code

I.9. Country of destination

ISO code

I.10. Region of destination

Code

I.11. Place of origin Embryo team

Name Approval number

Address Name Approval number

Address Name Approval number

Address

I.12. Place of destination Holding Embryo team Approved body

Name Approval number

Address Postal code

I.13.

I.14. Estimated date and time of arrival

I.15. Means of transport Aeroplane Ship Railway wagon

Road vehicle Other

Identification:

Documentary references:

I.16.

I.17.

I.18. Description of commodity

I.19. Commodity code (HS code)

I.20. Quantity

I.21.

I.22. Number of packages

I.23. Identification of container/Seal number

I.24.

I.25. Commodity certified for Artificial reproduction

I.26. For transit to third country vis-à-vis EU

third country ISO code

I.27. For import or admission into EU

Definitive import

I.28. Identification of the animals/products Species (Scientific name) Identification mark Category

Part I: Details of dispatched consignment

COUNTRY In vitro produced bovine embryos

II. Health information

II.a. Certificate reference number

II.b. Local reference number

I, the undersigned, official veterinarian of the Government of , (insert name of exporting country)

certify that:

1.1. the embryo production team identified above:

has been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC,

carried out the production, processing, storing and transport of the embryos described above in accordance with Chapter II of Annex A to Directive 89/556/EEC,

is subject to inspection by an official veterinarian at least twice a year.

1.2. the embryos to be exported were produced in the exporting country, which according to official findings:

1.2.1. was free from rinderpest during the 12 months immediately prior to their production;

1.2.2.

1.2.2.1. either was free from foot-and-mouth disease during the 12 months immediately prior to their production and did not carry out vaccination against foot-and-mouth disease during that period (1),

1.2.2.2. or was not free from foot-and-mouth disease during the 12 months immediately prior to their production and/or carried out vaccination against foot-and-mouth disease during that period, and

the embryos were produced without penetration of the zona pellucida,

the embryos were stored under approved conditions for at least 30 days immediately after their production, and

the donor females come from holdings on which no animal was vaccinated against foot-and-mouth disease during the 30 days prior to collection and no animal of a susceptible species showed clinical signs of foot-and-mouth disease during the 30 days prior to, and at least the 30 days after, the oocytes were collected (1);

1.3. the oocytes used in the production of the embryos to be exported were collected from donor females complying with the following requirements:

1.3.1. the donor females:

were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the oocytes (1), or

1.3.2.

were kept during a seasonally free period or protected from the competent vector Culicoides for at least 60 days prior to, and during, the collection of the oocytes, and the embryos were produced without penetration of the zona pellucida, except if the donors underwent a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection and giving negative results and the embryos were stored for at least 30 days (1), or

1.3.3.

underwent a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection and giving negative results, and the embryos were stored for at least 30 days (1), or

1.3.4.

underwent an agent identification test, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of collection or the day of slaughtering and giving negative results – the embryos having been produced, in the latter case, without penetration of the zona pellucida (1);

Part II: Certification

1.4.

1.4.1. within a 10 km radius of the premises on which the oocytes used in the production of the embryos to be exported were collected and processed, according to official findings there was no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia in the 30 days immediately prior to their collection and, in the case of embryos certified under 11.2.2.2, in the 30 days after their collection as well;

1.4.2. from the time of collection until 30 days thereafter, the embryos to be exported were stored at all times on approved premises within a 10 km radius of which, according to official findings, there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever;

1.5. the donors of oocytes used in the production of the embryos to be exported:

1.5.1. were located, during the 30 days immediately prior to collection of the oocytes, on premises within a 10 km radius of which, according to official findings, there was no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, contagious vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia;

1.5.2. showed no clinical signs of disease on the day of collection;

1.5.3. spent the six months immediately prior to collection within the territory of the exporting country in no more than two herds:

which, according to official findings, were free from tuberculosis during that time,

which, according to official findings, were free from brucellosis during that time,

which were free from enzootic bovine leukosis or in which no animal showed clinical signs of enzootic bovine leukosis during the previous three years,

in which no bovine animal showed clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis during the previous 12 months;

1.6. the embryos to be exported provide the following additional guarantees (3):

1.6.1. either the embryos to be exported were produced in the exporting country, which according to official findings is free from Akabane disease (1),

1.6.2. or the embryos were produced in the exporting country, which according to official findings is not free from Akabane disease (1), and

the embryos were produced without penetration of the zona pellucida;

the embryos were stored under approved conditions for at least 30 days immediately after production, and

the donors of the oocytes used in the production of embryos underwent a serum neutralisation test for Akabane disease giving negative results and carried out on a blood sample taken not less than 21 days following their collection, or an agent identification test carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of slaughtering (1);

1.7. the embryos to be exported were conceived by in vitro fertilisation using semen coming from semen collection or storage centres located in a Member State of the European Community or in a third country and approved in accordance with Article 5(1) and Article 9(1) respectively of Directive 88/407/EEC (5).

Notes

(1) Delete as appropriate.

(2) (Box reference No I.28 in Part I):

Identification mark: corresponding to the identification of the donor cows and the date of collection.

Category: specify if a) penetration or b) non penetration of zona pellucida.

(3) See remarks for exporting country concerned in Annex I to Decision 2006/168/EC.

(4) The signature and the stamp must be of a different colour from that of the printed form.

(5) Semen collection and storage centres approved in accordance with EC legislation are listed on the Commission’s website http://europa.eu.int/comm/food/index_en.htm.

NB: This certificate must:

(a) be drawn up in at least one official language of the Member State of destination and of the Member State where the embryos will enter Community territory;

(b) be made out to a single consignee;

(c) accompany the embryos in the original.

Official veterinarian Name (in capital letters): Qualification and title

Date: Signature:

Stamp

COUNTRY Veterinary certificate to EU

I.1. Consignor

Name Address Postal code

I.2.

I.2.a. Local reference number:

I.3. Central Competent Authority

I.4. Local Competent Authority

I.5. Consignee Name Address Postal code

I.6.

I.7. Country of origin

ISO code

I.8. Region of origin

Code

I.9. Country of destination

ISO code

I.10. Region of destination

Code

I.11. Place of origin Embryo team

Name Approval number

Address Name Approval number

Address Name Approval number

Address

I.12. Place of destination Holding Embryo team Approved body

Name Approval number

Address Postal code

I.13.

I.14. Estimated date and time of arrival

I.15. Means of transport Aeroplane Ship Railway wagon

Road vehicle Other

Identification:

Documentary references:

I.16.

I.17.

I.18. Description of commodity

I.19. Commodity code (HS code)

I.20. Quantity

I.21.

I.22. Number of packages

I.23. Identification of container/Seal number

I.24.

I.25. Commodity certified for Artificial reproduction

I.26. For transit to third country vis-à-vis EU

third country ISO code

I.27. For import or admission into EU

Definitive import

I.28. Identification of the animals/products Species (Scientific name) Identification mark Category

Part I: Details of dispatched consignment

COUNTRY In vitro produced bovine embryos using semen from semen centres approved by the exporting country

II. Health information

II.a. Certificate reference number

II.b. Local reference number

I, the undersigned, official veterinarian of the Government of , (insert name of exporting country)

certify that:

1.1. the embryo production team identified above:

has been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC,

carried out the production, processing, storing and transport of the embryos described above in accordance with Chapter II of Annex A to Directive 89/556/EEC,

is subject to inspection by an official veterinarian at least twice a year;

1.2. the embryos to be exported were produced in the exporting country, which according to official findings:

1.2.1. was free from rinderpest during the 12 months immediately prior to the production of the embryos;

1.2.2.

1.2.2.1. either was free from foot-and-mouth disease during the 12 months immediately prior to the production of the embryos and did not carry out vaccination against foot-and-mouth disease during that period (1),

1.2.2.2. or was not free from foot-and-mouth disease during the 12 months immediately prior to the production of the embryos and/or carried out vaccination against foot-and-mouth disease during that period, and

the embryos were produced without penetration of the zona pellucida,

the embryos were stored under approved conditions for at least 30 days immediately after production, and

the donor females come from holdings on which no animal was vaccinated against foot-and-mouth disease during the 30 days prior to collection and no animal of a susceptible species showed clinical signs of foot-and-mouth disease during the 30 days prior to, and at least the 30 days after, the oocytes were collected (1);

1.3. the oocytes used in the production of the embryos to be exported were collected from donor females complying with the following requirements:

1.3.1. the donor females:

were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, the collection of the oocytes (1), or

1.3.2.

were kept during a seasonally free period or protected from the competent vector Culicoides for at least 60 days prior to, and during, the collection of the oocytes and the embryos were produced without penetration of the zona pellucida, except if the donors underwent a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection and giving negative results, and the embryos were stored for at least 30 days (1), or

1.3.3.

underwent a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection and giving negative results, and the embryos were stored for at least 30 days (1), or

1.3.4.

underwent an agent identification test, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of collection or the day of slaughtering and giving negative results — the embryos having been produced, in the latter case, without penetration of the zona pellucida (1);

Part II: Certification

1.4.

1.4.1. within a 10 km radius of the premises on which the oocytes used in the production of the embryos to be exported were collected and processed, according to official findings there was no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia in the 30 days immediately prior to their collection and, in the case of embryos certified under 11.2.2.2, in the 30 days after their collection as well;

1.4.2. from the time of collection until 30 days thereafter, the embryos to be exported were stored at all times on approved premises within a 10 km radius of which, according to official findings, there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever;

1.5. the donors of oocytes used in the production of the embryos to be exported:

1.5.1. were located, during the 30 days immediately prior to collection of the oocytes, on premises within a 10 km radius of which, according to official findings, there was no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, contagious vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia;

1.5.2. showed no clinical signs of disease on the day of collection;

1.5.3. spent the six months immediately prior to collection within the territory of the exporting country in no more than two herds:

which, according to official findings, were free from tuberculosis during that time,

which, according to official findings, were free from brucellosis during that time,

which were free from enzootic bovine leukosis or in which no animal showed clinical signs of enzootic bovine leukosis during the previous three years,

in which no bovine animal showed clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis during the previous 12 months;

1.6. the embryos to be exported provide the following additional guarantees (3):

1.6.1. either the embryos to be exported were produced in the exporting country, which according to official findings is free from Akabane disease (1),

1.6.2. or the embryos to be exported were produced in the exporting country, which according to official findings is not free from Akabane disease (1), and

they were produced without penetration of the zona pellucida;

they were stored under approved conditions for at least 30 days immediately after production, and

the donors of the oocytes used in the production of the embryos underwent a serum neutralisation test for Akabane disease giving negative results, carried out on a blood sample taken not less than 21 days following their collection, or an agent identification test carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of slaughtering (1);

1.7. the embryos to be exported were conceived by in vitro fertilisation using semen coming from semen collection or storage centres approved for the collection, processing and/or storage of semen by the competent authority of a country listed in Annex I to Commission Decision 2004/639/EC (5) or by the competent authority of a Member State of the European Community.

Notes

(1) Delete as appropriate.

(2) (Box reference No I.28 in Part I):

Identification mark: corresponding to the identification of the donor cows and the date of collection.

Category: specify if (a) penetration or (b) non penetration of zona pellucida.

(3) See remarks for exporting country concerned in Annex I to Decision 2006/168/EC.

(4) The signature and the stamp must be of a different colour from that of the printed form.

(5) OJ L 292, 15.9.2004, p. 21.

NB: This certificate must:

(a) be drawn up in at least one official language of the Member State of destination and of the Member State where the embryos will enter Community territory;

(b) be made out to a single consignee;

(c) accompany the embryos in the original.

Information: in accordance with Article 3(a) of Council Directive 89/556/EEC, embryos imported under the conditions laid down in this certificate are excluded from intra-Community trade.

Official veterinarian Name (in capital letters): Qualification and title

Date: Signature:

Stamp

1. Country of provenance and competent authority.

2. Health certificate No:

A. ORIGIN OF EMBRYOS

3. Approval number of the embryo collection team or embryo production team (1):

4. Name and address of the embryo collection team or embryo production team (1):

5. Name and address of the consignor:

6. Country and place of loading:

7. Means of transport:

B. DESTINATION OF EMBRYOS

8. Member State of destination:

9. Name and address of the consignee:

C. IDENTIFICATION OF EMBRYOS

10.1. Identification mark of embryos (2)

10.2. Number of embryos

10.3. Produced embryos (1)

(a) Derived by in vitro fertilisation

(b) Subjected to penetration of zona pellucida

10.4. Date of collection or production

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

(a) yes/no (1)

(b) yes/no (1)

D. HEALTH INFORMATION

11. I, the undersigned official veterinarian of the Government of

(insert name of exporting country)

certify that:

11.1. the embryo collection (1)/production (1) team identified above:

is approved in accordance with Chapter I of Annex A to Council Directive 89/556/EEC (3),

carried out the collection, processing, production (1) and storing and transport of the embryos described above in accordance with Chapter II of Annex A to Directive 89/556/EEC,

is subjected at least twice a year to inspection by an official veterinarian;

11.2. the embryos to be exported were collected (1) or produced (1) in the exporting country, which according to official findings:

11.2.1. has been free from rinderpest during 12 months immediately prior to the collection (1) or production (1) of the embryos;

11.2.2.

11.2.2.1. either has been free from foot-and-mouth disease during the 12 months immediately prior to collection (1) or production (1) of the embryos and has not practiced vaccination against foot-and-mouth disease during this period (1) , or

11.2.2.2. has not been free from foot-and-mouth disease for the 12 months immediately prior to the collection (1) or production (1) of the embryos and/or has practised vaccination against foot-and-mouth disease during this period, and

the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and

the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos come from a holding in which no animal has shown clinical signs of foot-and-mouth disease nor was vaccinated against foot-and-mouth disease during the 30 days prior to collection (1);

11.2.3.

11.2.3.1. either has been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection (1) or production (1) of the embryos to be exported and has not practiced vaccination against these diseases during this period (1) , or

11.2.3.2. has not been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection (1) or production (1) of the embryos to be exported and/or has practised vaccination against these diseases during this period, and

the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and

the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to an agar gel immuno diffusion test and a serum neutralisation test for the detection of antibodies against the epizootic haemorrhagic disease virus carried out with negative results on a blood sample taken not less than 21 days following collection (1);

11.3.

11.3.1. the premises on which the embryos to be exported or the ovaries, oocytes and other tissues used in the production of embryos to be exported were collected and processed were at the time of collection situated in the centre of an area of 20 km diameter in which according to official findings there had been no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia for 30 days immediately prior to collection and in the case of embryos certified under 11.2.2.2 and 11.2.3.2 for 30 days after collection;

11.3.2. between the time of collection or production of the embryos to be exported and their dispatch, they were stored continuously in approved premises which were situated in the centre of an area of 20 km in diameter in which according to official findings there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever;

11.4. the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos:

11.4.1. were located during the 30 days immediately prior to collection of the embryos to be exported in premises situated in the centre of an area of 20 km in diameter in which according to official findings there was during this period no incidence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever or contagious bovine pleuropneumonia;

11.4.2. showed no clinical sign of disease on the day of collection;

11.4.3. have spent the six months immediately prior to collection in the territory of the exporting country in a maximum of two herds:

which, according to official findings, have been free from tuberculosis,

which, according to official findings, have been free from brucellosis,

which have been free from enzootic bovine leukosis or in which no bovine animal has shown clinical signs of enzootic bovine leukosis during the previous three years,

in which no bovine animal has shown clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis during the previous 12 months;

11.5. the embryos comply with the following additional guarantees (4):

11.5.1. either the embryos to be exported were collected (1) or produced (1) in the exporting country, which according to official findings is free of Akabane disease (1),

or 11.5.2. the embryos to be exported were collected (1) or produced (1) in the exporting country, which according to official findings is not free of Akabane disease (1), and

the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and

the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to a serum neutralisation test for Akabane disease carried out with negative results on a blood sample taken not less than 21 days following collection (1).

11.6. The embryos to be exported were conceived as a result of artificial insemination or in vitro fertilisation with semen from a donor sire standing at a semen collection centre approved by the competent authority for the collection, processing and storage of semen or with semen imported from the European Community.

E. VALIDITY

12. Date and place

13. Name and qualification of the official veterinarian

14. Signature and stamp of the official veterinarian (5)

Note for guidance:

(1) Delete as appropriate.

(2) Corresponding to the identification of the donor cows and date of collection.

(3) OJ L 302, 19.10.1989, p. 1.

(4) See the remarks for the exporting country concerned in Annex I to Decision 2006/168/EC (OJ L 57, 28.2.2006, p. 19).

(5) The signature and the stamp must be in a colour different to that of printing.

Note: This certificate must:

(a) be drawn up in at least one of the official languages of the Member State of destination and the Member State where the embryos will enter Community territory;

(b) be made out to a single consignee;

(c) accompany the embryos in the original;

(d) not to be used after the date indicated in Article 4 of Decision 2006/168/EC.

Information: In accordance with Article 3(a) of Council Directive 89/556/EEC, embryos imported under the conditions laid down in this certificate are not eligible for intra-Community trade.